AVROBIO Announces Pricing of Underwritten Public Offering of $75 Million of Common Stock
(NASDAQ: AVRO), a leading clinical-stage gene therapy company, today announced the pricing of an underwritten public offering of 5,000,000 shares of ... http://dlvr.it/Rm4xBB
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.